Health Catalyst
HCAT
171 hedge funds and large institutions have $484M invested in Health Catalyst in 2022 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 77 increasing their positions, 41 reducing their positions, and 38 closing their positions.
88% more repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 41
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
3% less call options, than puts
Call options by funds: $2.28M | Put options by funds: $2.34M
5% less funds holding
Funds holding: 180 → 171 (-9)
6.29% less ownership
Funds ownership: 97.45% → 91.15% (-6.3%)
21% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 38
37% less capital invested
Capital invested by funds: $766M → $484M (-$282M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$17.5M |
| 2 |
JP Morgan Chase
New York
|
+$15.1M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
+$13.1M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$12.6M |
| 5 |
NI
Nepsis Inc
Minneapolis,
Minnesota
|
+$10.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
-$57.3M |
| 2 |
ClearBridge Investments
New York
|
-$30.8M |
| 3 |
Aberdeen Group
Edinburgh,
United Kingdom
|
-$20.6M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$12.6M |
| 5 |
ACM
Ashford Capital Management
Wilmington,
Delaware
|
-$12M |
HCAT Hedge Fund Activity: Q3 2022 in Review
171 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Health Catalyst (HCAT) for Q3 2022, worth a combined $484M — down 37% from $766M a quarter earlier.
Sellers outnumbered buyers: 38 funds closed out of HCAT and 30 opened new positions — a net loss of 8 holders — while 41 trimmed existing stakes and 77 added.
The largest buyer was Millennium Management, adding an estimated $17.5M. The largest seller was AllianceBernstein, cutting an estimated $57.3M.
- 171 institutional investors held Health Catalyst (HCAT) as of Q3 2022, down from 180 in Q2 2022.
- Funds reported $484M of Health Catalyst stock for Q3 2022, down 37% quarter-over-quarter.
- 30 funds opened new Health Catalyst positions in Q3 2022 and 38 closed out, a net change of -8 holders.
- The largest Health Catalyst buyer in Q3 2022 was Millennium Management, an estimated $17.5M added.
- The largest Health Catalyst seller in Q3 2022 was AllianceBernstein, an estimated $57.3M sold.
Based on aggregated 13F filings for Q3 2022.